UBS UBS
Company Profile ↓Company Overview
UBS (UBS) is a publicly traded company listed on with a market capitalization of $179.01B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 12.4% CAGR over the past five years.
Maintains a net profit margin of 16.4%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $47.30B (+4.3% YoY); net profit $7.77B.
- Trailing 12 Months Year-on-year growth — revenue +4.3%, earnings +52.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 12.4%, profit CAGR 0.6%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 12.44% |
| 1 Year: | 4.30% |
Compounded Profit Growth
| 5 Years: | 0.60% |
| 1 Year: | 52.71% |
Stock Price Performance
| 1 Year: | +49.86% |
| 6 Months: | +15.28% |
| 3 Months: | +21.47% |
| 1 Month: | +4.14% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)59.48 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 12.4% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | - | - | 11.52B | 11.94B | 12.20B | 13.77B | 13.35B |
| Cost of Revenue | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Interest Expense | - | 6.95B | 6.82B | 6.58B | 6.20B | 5.74B | - |
| Pretax Income | - | - | 2.19B | 2.83B | 1.70B | 3.84B | 3.59B |
| Tax Provision | - | - | -209.00M | 341.00M | 495.00M | 786.00M | 782.00M |
| Net Income | - | - | 2.40B | 2.48B | 1.20B | 3.04B | 2.80B |
| Diluted EPS | - | - | 0.72 | 0.76 | 0.37 | 0.94 | 0.22 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 33.27B | 41.14B | 45.35B | 47.30B |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 6.56B | 28.22B | 35.95B | 26.55B |
| Pretax Income | - | 9.60B | 28.25B | 6.82B | 8.85B |
| Tax Provision | - | 1.94B | 873.00M | 1.68B | 1.06B |
| Net Income | - | 7.63B | 27.37B | 5.09B | 7.77B |
| Diluted EPS | - | 2.25 | 8.30 | 1.52 | 2.36 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 1.10T | 1.72T | 1.57T | 1.62T |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 172.82B | 317.12B | 225.71B | 211.01B |
| Inventory | - | - | - | - | - |
| Receivables | - | 20.65B | 26.78B | 30.21B | 40.28B |
| Total Liabilities | - | 1.05T | 1.63T | 1.48T | 1.53T |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | 160.27B | 333.65B | 297.32B | 297.92B |
| Total Debt | - | 193.28B | 377.69B | 332.42B | 336.04B |
| Total Equity | - | 56.88B | 85.62B | 85.08B | 90.21B |
| Shares Outstanding | - | 3.52B | 3.46B | 3.46B | 3.34B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 14.65B | 86.07B | 3.28B | 21.85B |
| Investing Cash Flow | - | -12.45B | 103.12B | 709.00M | -22.80B |
| Financing Cash Flow | - | -9.09B | -58.26B | -84.17B | -30.86B |
| Capital Expenditure | - | -1.64B | -1.69B | -2.01B | -2.36B |
| Free Cash Flow | - | 13.00B | 84.38B | 1.27B | 19.49B |
| Net Change in Cash | - | -6.89B | 130.93B | -80.18B | -31.81B |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 22.9% | 66.5% | 11.2% | 16.4% |
| ROE % | - | 13.4% | 32.0% | 6.0% | 8.6% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for UBS
Cisco Systems to report amid expectations of continued AI infrastructure strength
Cisco Systems Inc (NASDAQ:CSCO, XETRA:CIS) is set to report quarterly results after the market close on August 12, with UBS expecting the networking equipment maker to deliver revenue and earnings above consensus estimates, supported by acc…
Walmart seen delivering steady second quarter as UBS backs long-term earnings story
Walmart Inc (NYSE:WMT, XETRA:WMT)'s upcoming second quarter earnings report could act as a positive catalyst for the stock despite expectations for slower comparable sales growth, according to UBS analysts, which argued that investors are f…
Expeditors International of Washington's Topline Momentum Expected to Continue, UBS Says
Expeditors International of Washington's (EXPD) topline momentum is expected to continue, as key dri
Itau Unibanco Q2 Earnings & Revenues Rise Y/Y Despite Higher Expenses
ITUB's Q2 results benefit from higher operating revenues and managerial financial margin. However, higher expenses and credit costs remain headwinds.
European Banks Resurge: Deutsche Bank and UBS Beat On Par With Wall Street
The European banking sector is facing a re-rating this year, led by a “higher for longer” interest rate environment that continues to enhance net interest margins across core lending books. The doubling of the EURO STOXX Banks Index in the …
Crescent Energy (CRGY) Stock Gets Fair Value Trim As Analysts Rework Oil Assumptions
The fair value estimate for Crescent Energy has shifted from about US$17.36 to roughly US$15.93, which places it closer to the current cluster of analyst price targets between US$13 and US$18. This change aligns with recent commentary that …
UBS — Frequently Asked Questions
What is the current share price of UBS?
As of 2026-08-05 17:25 PDT, UBS trades at $53.57 on NASDAQ/NYSE. Its 52-week range is $35.49 to $55.07.
What is the market capitalisation of UBS?
UBS has a market capitalisation of $179.01B on NASDAQ/NYSE.
What is the P/E ratio of UBS?
UBS trades at a trailing price-to-earnings (P/E) ratio of 22.70. Its price-to-book (P/B) ratio is 1.98.
What is the return on equity (ROE) of UBS?
UBS has a return on equity (ROE) of 8.61%.
Is UBS a good stock to buy?
This page provides a data-driven analysis of UBS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.